MAPK3 and breast cancer: Autocrine activation of protease-activated receptor-2 (PAR-2) by trypsin-like serine proteases secreted in a metastatic breast cancer cell line may promote metastatic tumor cell migration through β-arrestin2-dependent ERK1/2 activation [61].